Tomoaki Kaizuka

1PUBLICATIONS
0CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Mar 09, 2023
Final analysis of a post-marketing surveillance study of dabrafenib and trametinib combination therapy in Japanese patients with unresectable malignant melanoma with BRAF V600 mutation.

Tomoaki Kaizuka, Ryohei Kurihara, Miki Harumiya

Pageof 1

Frequent Collaborators